Abstract
The prognostic significance of c-erbB-2 oncoprotein overexpression detected in tumours by immunocytochemical assays (ICAs) was investigated in 148 breast carcinomas. ICAs were performed under optimal technical conditions with frozen tissue sections and included automated immunoperoxidase technique and computer-assisted analysis (densitometry) of digitized coloured microscopic images. Results of quantitative ICAs (expressed in percentages of c-erbB-2-positive surfaces and mean optical densities) were correlated with the patients' follow-up in axillary lymph node-positive (N+) and node-negative (N-) subgroups of patients. Patients' follow-up ranged from 9 months (for the first death) to 101 months (for the 121 alive patients) with a 62.5 months mean overall follow-up. It was shown that marked c-erbB-2 immunocytochemical expression in tumours (cut-off point 35%) significantly correlated with the patients' poor overall survival in N+ and in N- patients (Kaplan-Meier, log-rank test, P = 0.045 and P = 0.015). Also, marked c-erbB-2 immunohistochemical expression correlates with short disease-free (P = 0.005), recurrence-free (P = 0.048) and metastasis-free survival (P = 0.05) (Kaplan-Meier, log-rank test) in N+, but not in N- subgroup...Continue Reading
Citations
Feb 9, 2000·American Journal of Clinical Pathology·D C Allred, P E Swanson
Feb 6, 2004·Molecular & Cellular Proteomics : MCP·Jeffrey S RossGabriel N Hortobagyi
Oct 14, 2004·British Journal of Cancer·D M Abd El-RehimI O Ellis
Dec 26, 2006·Expert Review of Molecular Diagnostics·Jennifer LaudadioDaynna J Wolff
Apr 11, 2012·International Journal of Molecular Sciences·Sara SantosRaquel Chaves
Mar 17, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R C BastUNKNOWN American Society of Clinical Oncology Tumor Markers Expert Panel
Dec 18, 2001·The Journal of Pathology·J M BartlettT G Cooke
Apr 7, 2009·The Oncologist·Jeffrey S RossGabriel N Hortobagyi
Mar 31, 1999·British Journal of Cancer·S J HoustonD W Miles
Aug 5, 2003·The Oncologist·Jeffrey S RossKenneth J Bloom
Feb 27, 2003·The Breast Journal·Helen SwedeArthur M Michalek
Mar 2, 2011·Medical Oncology·Pietro SanpaoloVincenzo Fusco
Jan 13, 2006·Annals of Surgical Oncology·S David NathansonMichael Linden
Jan 5, 2014·PloS One·Sara SantosRaquel Chaves
Mar 2, 2002·The British Journal of Surgery·D S LeonardN J O'Higgins
Jan 7, 2000·Journal of Cellular Physiology·S MénardS M Pupa
Dec 1, 1998·Stem Cells·J S Ross, J A Fletcher